Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn about the dangers of holding cash. This guide will help you understand the potential risks involved with cash savings.
18,190 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A new Ripple survey shows banks leaning into digital assets, with stablecoins leading cash-flow efficiency. For XRP, ...
Markets edged lower in March as crypto regulation chatter intensified. Circle CRCL led the headlines with a sharp mov...
Casey’s General Stores posted stronger fuel margins and a growing Rewards base, lifting investor optimism. Analysts c...
When Gartner stock sagged today, traders weighed a price-target cut and the broader tech sentiment. This article brea...
Gas prices in Ohio are climbing faster than many states. This article breaks down the local factors driving the surge...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
Strategy adds 535 BTC for roughly $43 million, expanding a monumental on-balance-asset position. The total stake now ...
As interest rates climb, even active managers recalibrate risk. Advocacy Wealth Management recently trimmed a major P...
Housing stocks depression mode is taking hold as major builders and appliance makers slump despite a rising S&P 500. ...
Publishers, printers, and retailers are adapting to inflation, backlogs, and shifting demand as the journey from prop...
As the Dow breaks above 50,000 in early 2026, investors revisit the ghost 36,000 milestone and debate whether old bet...